Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D003131:Combined Modality Therapy; D006152:Cyclic GMP / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D015316:Genetic Therapy; D008297:Male; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D010410:Penile Erection / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D011687:Purines; D051381:Rats; D011919:Rats, Inbred Strains; D000068677:Sildenafil Citrate; D013450:Sulfones; D014162:Transfection; D014665:Vasodilator Agents / Q000494:pharmacology*
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; C496316:Nos3 protein, rat; D006152:Cyclic GMP